Rapid Micro Biosystems (RPID)
(Delayed Data from NSDQ)
$3.37 USD
+0.15 (4.66%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $3.34 -0.03 (-0.89%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth D Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
RPID 3.37 +0.15(4.66%)
Will RPID be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for RPID based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for RPID
Rapid Micro Biosystems, Inc. (RPID) Reports Q2 Loss, Misses Revenue Estimates
Artivion (AORT) Tops Q2 Earnings and Revenue Estimates
RPID: What are Zacks experts saying now?
Zacks Private Portfolio Services
908 Devices Inc. (MASS) Reports Q2 Loss, Tops Revenue Estimates
Thermo Fisher Scientific (TMO) Tops Q2 Earnings and Revenue Estimates
Rapid Micro Biosystems, Inc. (RPID) Reports Q1 Loss, Tops Revenue Estimates
Other News for RPID
Pocket Pivot appears for RPID after 4.66% move
RPID Crossed Above 50 Day Moving Average on September 18
RPID forms MACD Bullish Centerline Cross on September 17
RPID Fell Below 50 Day Moving Average on September 16
Is RPID likely to continue higher? Crossed Above 50 Day Moving Average shows up after rising 4.13%